 |
|
|
|
home / corporate / management
 Management
Dobrin Nedelkov, Ph.D.
CEO and Scientific Director
Dr. Dobrin Nedelkov is a CEO and Scientific Director of Intrinsic Bioprobes, Inc. Prior to joining Intrinsic Bioprobes in 1999, Dr. Nedelkov was Postdoctoral Associate at Yale University, in the Department of Molecular Biophysics and Biochemistry. Dr. Nedelkov received his Ph.D. in Chemistry and Biochemistry from Arizona State University in 1997.
As a result of his involvement in the application of affinity-based mass spectrometry approaches for high-throughput protein analysis, Dr. Nedelkov introduced the concept of Population Proteomics as a paradigm shift in the study of protein diversity in human populations. Dr. Nedelkov has authored over 60 peer reviewed scientific articles, presented at over 40 scientific meetings, and served as a reviewer on over 20 NIH scientific panel. He is also a co-author on several patent applications, and Principal Investigator on a number of NIH-funded projects.
Past Management
Randall W. Nelson, Ph.D.
Founder and President
Dr. Nelson founded IBI in 1996 and has served as its President ever since. Prior to forming IBI, Dr. Nelson served on the faculty in the Department of Chemistry/Biochemistry at Arizona State University, where he received his Ph.D. in Analytical Chemistry in 1990. Dr. Nelson served from 1990-1993 as MALDI-TOF MS product manager at Vestec Corporation, Houston, TX, where he directed the manufacture of the world's first commercial MALDI-TOF line of mass spectrometers. Dr. Nelson holds numerous patents in the field of biological mass spectrometry and has authored over 70 publications and given numerous talks in the field of biological mass spectrometry. Dr. Nelson is currently a Research Professor and Director of the Molecular Biosignatures Analysis Unit at The Biodesign Institute, Arizona State University.
|
|
 |
|
|
